{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:36:47Z","timestamp":1790026607772,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 109-2314-B-002-146-MY3"],"award-info":[{"award-number":["MOST 109-2314-B-002-146-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 110-2314-B-002-064-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-002-064-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2314-B-002-209-MY3"],"award-info":[{"award-number":["NSTC 112-2314-B-002-209-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastroenterol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s00535-024-02162-3","type":"journal-article","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T21:01:54Z","timestamp":1729630914000},"page":"107-117","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of age at HBsAg seroclearance on hepatic outcomes and life expectancy in men with chronic HBV infection based on multi-state modeling of the natural history"],"prefix":"10.1007","volume":"60","author":[{"given":"Wen-Jie","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jung","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-0993","authenticated-orcid":false,"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5196-7030","authenticated-orcid":false,"given":"Yi-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8371-6236","authenticated-orcid":false,"given":"Ming-Whei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,22]]},"reference":[{"key":"2162_CR1","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"GBD 2019 Hepatitis B Collaborators","year":"2022","unstructured":"GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol. 2022;7:796\u2013829.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2162_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/s41575-022-00649-z","volume":"19","author":"A Kramvis","year":"2022","unstructured":"Kramvis A, Chang KM, Dandri M, et al. A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook. Nat Rev Gastroenterol Hepatol. 2022;19:727\u201345.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2162_CR3","first-page":"8","volume":"3","author":"AS Lok","year":"2018","unstructured":"Lok AS. Hepatitis B treatment: what we know now and what remains to be researched. Hepatol Commun. 2018;3:8\u201319.","journal-title":"Hepatol Commun"},{"key":"2162_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.jhep.2020.04.013","volume":"73","author":"I Tout","year":"2020","unstructured":"Tout I, Loureiro D, Mansouri A, et al. Hepatitis B surface antigen seroclearance: Immune mechanisms, clinical impact, importance for drug development. J Hepatol. 2020;73:409\u201322.","journal-title":"J Hepatol"},{"key":"2162_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","volume":"70","author":"TC Yip","year":"2019","unstructured":"Yip TC, Wong GL, Chan HL, et al. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues. J Hepatol. 2019;70:361\u201370.","journal-title":"J Hepatol"},{"key":"2162_CR6","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cgh.2020.05.041","volume":"19","author":"RT Anderson","year":"2021","unstructured":"Anderson RT, Choi HSJ, Lenz O, et al. Association between seroclearance of hepatitis B surface antigen and long-term clinical outcomes of patients with chronic hepatitis B virus infection: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19:463\u201372.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2162_CR7","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2147\/JHC.S355540","volume":"9","author":"RC Hsueh","year":"2022","unstructured":"Hsueh RC, Wu WJ, Lin CL, et al. Impact of PNPLA3 p. I148M and hepatic steatosis on long-term outcomes for hepatocellular carcinoma and HBsAg seroclearance in chronic hepatitis B. J Hepatocell Carcinoma. 2022;9:301\u201313.","journal-title":"J Hepatocell Carcinoma"},{"key":"2162_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jhep.2022.11.020","volume":"78","author":"TC Yip","year":"2023","unstructured":"Yip TC, Wong VW, Lai MS, et al. Risk of hepatic decompensation but not hepatocellular carcinoma decreases over time in patients with hepatitis B surface antigen loss. J Hepatol. 2023;78:524\u201333.","journal-title":"J Hepatol"},{"key":"2162_CR9","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jhep.2014.11.031","volume":"62","author":"GA Kim","year":"2015","unstructured":"Kim GA, Lee HC, Kim MJ, et al. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance. J Hepatol. 2015;62:1092\u20139.","journal-title":"J Hepatol"},{"key":"2162_CR10","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.jhep.2017.06.019","volume":"67","author":"TC Yip","year":"2017","unstructured":"Yip TC, Chan HL, Wong VW, et al. Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2017;67:902\u20138.","journal-title":"J Hepatol"},{"key":"2162_CR11","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1002\/hep.31610","volume":"73","author":"J Choi","year":"2021","unstructured":"Choi J, Yoo S, Lim YS. Comparison of long-term clinical outcomes between spontaneous and therapy-induced HBsAg seroclearance. Hepatology. 2021;73:2155\u201366.","journal-title":"Hepatology"},{"key":"2162_CR12","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jhep.2022.03.032","volume":"77","author":"H Yang","year":"2022","unstructured":"Yang H, Bae SH, Nam H, et al. A risk prediction model for hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol. 2022;77:632\u201341.","journal-title":"J Hepatol"},{"key":"2162_CR13","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.cgh.2017.12.009","volume":"16","author":"TC Yip","year":"2018","unstructured":"Yip TC, Wong VW, Chan HL, et al. Effects of diabetes and glycemic control on risk of hepatocellular carcinoma after seroclearance of hepatitis B surface antigen. Clin Gastroenterol Hepatol. 2018;16:765\u201373.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2162_CR14","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1111\/jvh.12905","volume":"25","author":"XJ Kuang","year":"2018","unstructured":"Kuang XJ, Jia RR, Huo RR, et al. Systematic review of risk factors of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Viral Hepat. 2018;25:1026\u201337.","journal-title":"J Viral Hepat"},{"key":"2162_CR15","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.gastro.2018.10.027","volume":"156","author":"YH Yeo","year":"2019","unstructured":"Yeo YH, Ho HJ, Yang HI, et al. Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis. Gastroenterology. 2019;156:635\u201346.","journal-title":"Gastroenterology"},{"key":"2162_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","volume":"10","author":"SK Sarin","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1\u201398.","journal-title":"Hepatol Int"},{"key":"2162_CR17","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1200\/JCO.2008.16.1075","volume":"26","author":"MW Yu","year":"2008","unstructured":"Yu MW, Shih WL, Lin CL, et al. Body-mass index and progression of hepatitis B: a population-based cohort study in men. J Clin Oncol. 2008;26:5576\u201382.","journal-title":"J Clin Oncol"},{"key":"2162_CR18","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1053\/j.gastro.2017.07.001","volume":"153","author":"MW Yu","year":"2017","unstructured":"Yu MW, Lin CL, Liu CJ, et al. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study. Gastroenterology. 2017;153:1006\u201317.","journal-title":"Gastroenterology"},{"key":"2162_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/1040-8428(94)90020-5","volume":"17","author":"MW Yu","year":"1994","unstructured":"Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol. 1994;17:71\u201391.","journal-title":"Crit Rev Oncol Hematol"},{"key":"2162_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v038.i07","volume":"38","author":"LC de Wreede","year":"2011","unstructured":"de Wreede LC, Fiocco M, Putter H. mstate: an R package for the analysis of competing risks and multi-state models. J Stat Softw. 2011;38:1\u201330.","journal-title":"J Stat Softw"},{"key":"2162_CR21","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/S2666-7568(21)00308-1","volume":"3","author":"JT Neumann","year":"2022","unstructured":"Neumann JT, Thao LTP, Callander E, et al. A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data. Lancet Healthy Longev. 2022;3:e89\u201397.","journal-title":"Lancet Healthy Longev"},{"key":"2162_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29138","volume":"95","author":"WJ Wu","year":"2023","unstructured":"Wu WJ, Lin CL, Liu CJ, et al. Lifetime risk of liver-related outcomes and determinants in male inactive carriers of chronic hepatitis B. J Med Virol. 2023;95: e29138.","journal-title":"J Med Virol"},{"key":"2162_CR23","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/carcin\/bgm252","volume":"29","author":"CF Wu","year":"2008","unstructured":"Wu CF, Yu MW, Lin CL, et al. Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men. Carcinogenesis. 2008;29:106\u201312.","journal-title":"Carcinogenesis"},{"key":"2162_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.3390\/v14020434","volume":"14","author":"RN Chien","year":"2022","unstructured":"Chien RN, Liaw YF. Current trend in antiviral therapy for chronic hepatitis B. Viruses. 2022;14:434.","journal-title":"Viruses"},{"key":"2162_CR25","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1002\/hep.27610","volume":"61","author":"YC Hung","year":"2015","unstructured":"Hung YC, Lin CL, Liu CJ, et al. Development of risk scoring system for stratifying population for hepatocellular carcinoma screening. Hepatology. 2015;61:1934\u201344.","journal-title":"Hepatology"},{"key":"2162_CR26","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/hep.30339","volume":"69","author":"YH Wang","year":"2019","unstructured":"Wang YH, Chuang YH, Wu CF, et al. Smoking and hepatitis B virus-related hepatocellular carcinoma risk: the mediating roles of viral load and alanine aminotransferase. Hepatology. 2019;69:1412\u201325.","journal-title":"Hepatology"},{"key":"2162_CR27","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1001\/jamaoncol.2018.0035","volume":"4","author":"K Kim","year":"2018","unstructured":"Kim K, Choi S, Park SM. Association of high body mass index and hepatocellular carcinoma in patients with chronic hepatitis B virus infection: a Korean population-based cohort study. JAMA Oncol. 2018;4:737\u20139.","journal-title":"JAMA Oncol"},{"key":"2162_CR28","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1093\/jnci\/dji043","volume":"97","author":"MW Yu","year":"2005","unstructured":"Yu MW, Yeh SH, Chen PJ, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. J Natl Cancer Inst. 2005;97:265\u201372.","journal-title":"J Natl Cancer Inst"},{"key":"2162_CR29","doi-asserted-by":"publisher","first-page":"6012","DOI":"10.3390\/cancers14236012","volume":"14","author":"MW Yu","year":"2022","unstructured":"Yu MW, Lin CL, Liu CJ, et al. Metabolic-associated fatty liver disease, hepatitis B surface antigen seroclearance, and long-term risk of hepatocellular carcinoma in chronic hepatitis B. Cancers (Basel). 2022;14:6012.","journal-title":"Cancers (Basel)"},{"key":"2162_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3350\/cmh.2023.0004","volume":"29","author":"YJ Wong","year":"2023","unstructured":"Wong YJ, Nguyen VH, Yang HI, et al. Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis. Clin Mol Hepatol. 2023;29:705\u201320.","journal-title":"Clin Mol Hepatol"}],"container-title":["Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02162-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00535-024-02162-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00535-024-02162-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T13:04:37Z","timestamp":1736427877000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00535-024-02162-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["2162"],"URL":"https:\/\/doi.org\/10.1007\/s00535-024-02162-3","relation":{},"ISSN":["0944-1174","1435-5922"],"issn-type":[{"value":"0944-1174","type":"print"},{"value":"1435-5922","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,22]]},"assertion":[{"value":"14 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}